Markoska K, et al. – Urinary peptide biomarkers associated with an improvement in estimated GFR (eGFR) over time were explored, and experts sought to improve patient stratification. In this study, a panel of urinary peptide markers was built that was able to discriminate those patients predisposed to improve their kidney function over time and possibly be treated with more specific or less aggressive therapy.